Evaluation and management of toxicity of cytoreductive surgery/hyperthermic intraperitoneal chemotherapy: the initial experience of a single centre study

Evaluation and management of toxicity of cytoreductive surgery/hyperthermic intraperitoneal chemotherapy: the initial experience of a single centre study

Background: Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) is a treatment modality for peritoneal surface malignancies with efficacy reported in many trials. Discrepancies, however, in the indication criteria, the extent of the surgical procedure, HIPEC regimens an...

Full description

Bibliographic Details
Main Authors:	Radmila Lemstrova, Dominika Flasarova, Martina Spisarova, Bohuslav Melichar, Martin Lovecek, Roman Havlik, Cestmir Neoral, Beatrice Mohelnikova-Duchonova, Dusan Klos
Format:	Article
Language:	English
Published:	Palacký University Olomouc, Faculty of Medicine and Dentistry 2020-09-01
Series:	Biomedical Papers
Subjects:	cytoreductive surgery hyperthermic intraperitoneal chemotherapy oxaliplatin mitomycin c cisplatin toxicity adverse events morbidity
Online Access:	https://biomed.papers.upol.cz/artkey/bio-202003-0012_evaluation-and-management-of-toxicity-of-cytoreductive-surgery-hyperthermic-intraperitoneal-chemotherapy-the-i.php

Similar Items

Epididymitis following Cytoreductive Surgery with Intraperitoneal Oxaliplatin Chemotherapy: Two Case Reports
by: Luiza Damian Ribeiro Barbosa, et al.
Published: (2016-02-01)

Perioperative management and postoperative outcome of patients undergoing cytoreduction surgery with hyperthermic intraperitoneal chemotherapy
by: Hamed Elgendy, et al.
Published: (2019-01-01)

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis: our initial experience of implementation and detailed technique
by: Talgat Uskenbayev, et al.
Published: (2019-06-01)

Is cytoreductive surgery and hyperthermic intraperitoneal chemotherapy indicated in hepatobiliary malignancies?
by: Natasha Leigh, et al.
Published: (2020-06-01)

Incidence and predictors of incisional hernia after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
by: Todd M. Tuttle, et al.
Published: (2019-01-01)

Anaesthetic management and perioperative outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: A retrospective analysis
by: Kalpana P Balakrishnan, et al.
Published: (2018-01-01)

Cytoreduction with Hyperthermic Intraperitoneal Chemotherapy and Renal Insufficiency Related to Diabetes Mellitus: An Anesthetic Challenge
by: Bartos Adrian, et al.
Published: (2017-10-01)

Cytoreduction with hyperthermic intraperitoneal chemotherapy: An anaesthetic challenge
by: Kavita Murughan, et al.
Published: (2014-01-01)

Colorectal peritoneal carcinomatosis treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: The experience of a tertiary Asian center
by: Melissa Ching Ching Teo, et al.
Published: (2015-04-01)

Impact of Neoadjuvant Chemotherapy on the Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: A Multi-Institutional Retrospective Review
by: Eliza W. Beal, et al.
Published: (2020-03-01)

Drain site enterocutaneous fistula after hyperthermic intraperitoneal chemotherapy
by: Navin Kumar, et al.
Published: (2021-01-01)

Cytoreduction plus hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis in colorectal cancer patients: a single-center cohort study
by: Leonardo Solaini, et al.
Published: (2019-03-01)

Risk factors of acute renal impairment after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
by: Chao-Yu Chen, et al.
Published: (2020-01-01)

Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma: patient selection and special considerations
by: Enomoto LM, et al.
Published: (2019-05-01)

Cytoreductive Surgery and Hyperthermic İntraperitoneal Chemoterapy for Advance Gastric Cancer Associated Peritoneal Carcinomatosis Single Centre Unit for 10 Consecutive Patients
by: Özgül Düzgün, et al.
Published: (2019-09-01)

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for appendiceal goblet cell carcinomas with peritoneal carcinomatosis: results from a single specialized center
by: Yu HH, et al.
Published: (2017-10-01)

Does the primary tumour location affect the prognosis of patients with colorectal cancer peritoneal metastases treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy?
by: Haipeng Chen, et al.
Published: (2021-08-01)

Experience of applying cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for ovarian teratoma with malignant transformation and peritoneal dissemination
by: Yu HH, et al.
Published: (2019-01-01)

Rhabdomyolysis after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Case Report
by: Rob Bielen, et al.
Published: (2013-01-01)

Multicystic peritoneal mesothelioma treated with cytoreductive surgery followed or not by hyperthermic intraperitoneal chemotherapy: results from a large multicentric cohort
by: Vahan Kepenekian, et al.
Published: (2021-01-01)

Prognostic significance of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in predicting outcomes for peritoneal carcinomatosis patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
by: Wei-Liang Loh, et al.
Published: (2017-01-01)

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) with cisplatin in pediatric patients with peritoneal mesothelioma: a single institution experience and long term follow up
by: Parisa Malekzadeh, et al.
Published: (2021-01-01)

The importance of primary tumor origin in gastrointestinal malignancies undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
by: Natasha Leigh, et al.
Published: (2020-07-01)

Cytoreductive interventions in combination with hyperthermic intraperitoneal chemoperfusion in pseudomyxoma
by: A. G. Abdullayev, et al.
Published: (2014-08-01)

The prognosis impact of hyperthermic intraperitoneal chemotherapy (HIPEC) plus cytoreductive surgery (CRS) in advanced ovarian cancer: the meta-analysis
by: Guyu Zhang, et al.
Published: (2019-04-01)

Current practices of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal surface malignancies: an international survey of oncologic surgeons
by: Heon Jong Yoo, et al.
Published: (2018-05-01)

High-grade postoperative complications affect survival outcomes of patients with colorectal Cancer peritoneal metastases treated with Cytoreductive surgery and Hyperthermic Intraperitoneal chemotherapy
by: Sicheng Zhou, et al.
Published: (2021-01-01)

Risk Factors and Prevention of Perioperative Venous Thromboembolism After Cytoreductive Surgery plus Hyperthermic Intraperitoneal Chemotherapy: An Analysis of 820 Cases
by: LI Xinbao, et al.
Published: (2019-02-01)

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei in a liver-transplanted patient: a case report
by: Ebbe Billmann Thorgersen, et al.
Published: (2018-09-01)

Complete pathologic response after two-stage cytoreductive surgery with HIPEC for bulky pseudomyxoma peritonei: proof of concept
by: Olivia Sgarbura, et al.
Published: (2020-01-01)

Trends in peritoneal surface malignancies: evidence from a Czech nationwide population-based study
by: Dušan Klos, et al.
Published: (2019-11-01)

The impact of ultrasound-guided bilateral rectus sheath block in patients undergoing cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy — a retrospective study
by: Shaoheng Wang, et al.
Published: (2020-08-01)

A Four-Inflow Construction to Ensure Thermal Stability and Uniformity during Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Rats
by: Daan R. Löke, et al.
Published: (2020-11-01)

Cytoreductive surgery and HIPEC (hyperthermic intraperitoneal chemotherapy) in combined treatment of ovarian cancer: time for the beginning of personalized therapy?
by: Yarema Roman, et al.
Published: (2019-09-01)

Administration of Low-Dose Dexmedetomidine Did Not Affect Acute Inflammatory Response after Cytoreductive Surgery Combined with Hyperthermic Intraperitoneal Chemotherapy: A Double-Blind Randomized Controlled Trial
by: Jiae Moon, et al.
Published: (2021-07-01)

Anesthesiological support of cytoreducative operations using hyperthermic intraperitoneal chemotherapy (hipec) in patients with ovaryan cancer
by: D. D. Morikov, et al.
Published: (2019-11-01)

Data on the quality of life after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignancies: does it concern patients with gastric cancer?
by: Skierucha Malgorzata, et al.
Published: (2017-12-01)

Clinical outcomes of complete cytoreduction with concurrent liver resection followed by hyperthermic intraperitoneal chemotherapy for synchronous peritoneal and liver metastatic colorectal cancer
by: Youngbae Jeon, et al.
Published: (2019-12-01)

Tonic-Clonic Seizure following Cytoreductive Surgery with Intraperitoneal Oxaliplatin: A Case Report and Review of the Literature
by: Jessica Sayuri Tsukamoto, et al.
Published: (2016-02-01)

Anesthetic management in an appendix tumor patient undergoing hyperthermic chemotherapy
by: Yonca Yanlı, et al.
Published: (2013-06-01)